Please assess the completion status of the following clinical trial:

Trial Title: Primary Prevention of Hypertension in Obese Adolescents

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~Children between the ages of 11 and 18~body mass index greater than the 95th percentile for age~Blood pressure between 75th and 95th percentile for age, gender and height percentile~Exclusion Criteria:~hypertension at the time of screening~allergy to one of the study medications~liver function abnormality (AST or ALT greater than twice the upper limit of~normal for the laboratory)~history of renal stones~renal insufficiency (Schwartz formula calculated GFR less than 70ml per min per 1.73m2 BSA)~positive urine pregnancy test~diabetes~organ transplant recipient~currently treated with an angiotensin converting enzyme inhibitor (ACEI), angiotensin receptor blocker (ARB), diuretic, other medications known to alter serum uric acid level~lack of ability to comply with the study protocol

- Gender: ALL
- Minimum Age: 11 Years
- Maximum Age: 18 Years
- Healthy Volunteers: t

Study Arms:
- Allopurinol (Type: EXPERIMENTAL): None
- Probenecid (Type: EXPERIMENTAL): None
- Placebo (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).